Multicellular living organisms and unmodified parts thereof and – Method of making a transgenic nonhuman animal – Via retrovirus
Reexamination Certificate
2008-01-29
2008-01-29
Schnizer, Richard (Department: 1635)
Multicellular living organisms and unmodified parts thereof and
Method of making a transgenic nonhuman animal
Via retrovirus
C435S456000, C435S320100, C435S325000, C536S024100, C800S019000
Reexamination Certificate
active
07323619
ABSTRACT:
The present invention relates to methods for producing transgenic animals, particularly transgenic birds and fish, using retroviral constructs engineered to carry the transgene(s) of interest.
REFERENCES:
patent: 5965789 (1999-10-01), Lubon et al.
patent: 5994136 (1999-11-01), Naldini et al.
patent: 6013516 (2000-01-01), Verma et al.
patent: 6080912 (2000-06-01), Bremel et al.
patent: 6580017 (2003-06-01), Echelard et al.
patent: 6891082 (2005-05-01), Lee et al.
patent: WO90/03439 (1990-04-01), None
patent: WO90/08832 (1990-08-01), None
patent: WO 00/29601 (2000-12-01), None
patent: WO 03/056019 (2003-07-01), None
Mizuarai et al (Biochim. Biophys. Res. Comm. 286: 456-463, 2001).
Deglon et al (Hum. Gene Therapy 11(1): 179-190, 2000).
Chiochetti et al (Biochim. Biophys. Acta (1352(2): 193-202, 1997).
Ivarie (TIBS 23(1): 14-19, 2003).
Alper (Science 300: 729-730, 2003.
Sang (Mech. Dev. 121: 1179-1186, 2004).
Kwon et al (Biochem. Biophys. Res. Comm. 320: 442-448, 2004).
Hoffman et al., “Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette” Proc. Natl. Acad. Sci.; vol. 93; pp. 5185-5190, May 1996.
Stover et al., “Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice.” Molecular Therapy vol. 3; No. 4, pp. 543-550, Apr. 2001.
Dougherty “Retrovirus Vecotrs for Efficient Transfer of Exogenous Genes into Target Cell Genomes”, Biotechnology Trends Pharmaceutical Technology, Apr. 1990.
Osbourne et al., “Relief of transcriptional silencing in LCT-beta-globin retroviral vectors assayed in transgenic mice”, 41stMeeting of the American Society of Hematology, New Blood, Nov. 1999, vol. 94, No. 10, pp. 177a.
Solaiman et al., “Modular retro-vectors for transgenic and therapeutic use”, Molecular Reproduction and Development, Jun. 2000, pp. 309-315.
Sukonnik et al., “Retrovirus vectors are rapidly silenced in de novo methylase knockout stem cells”, 42ndMeeting of the American Society of Hematology, San Francisco, Nov. 2000, vol. 96, No. 11, Part 1, pp. 429a.
Burns et al., “Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells,”Proc. Natl. Acad. Sci. USA, vol. 90, Sep. 1993, pp. 8033-8037.
Chan et al., “Transgenic cattle produced by reverse-transcribed gene transfer in oocytes,”Proc. Natl. Acad. Sci. USA, vol. 95, Nov. 1998, pp. 14028-14033.
Gordon et al., “Integration and Stable Germ Line Transmission of Genes Injected into Mouse Pronuclei,”Science, vol. 214, Dec. 11, 1981, pp. 1244-1246.
Jaenisch, “Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus,”Proc. Nat. Acad. Sci. USA, vol. 73, No. 4, Apr. 1976, pp. 1260-1264.
Miyoshi et al., “Development of a Self-Inactivating Lentivirus Vector,”Journal of Virology, vol. 72, No. 10, Oct. 1998, pp. 8150-5157.
Naldini et al., “In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector,”Science, vol. 272, Apr. 12, 1996, pp. 263-267.
Poeschla et al., “Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors,”Nature Medicine, vol. 4, No. 3, Mar. 1998, pp. 354-357.
Powell et al., “Breeding of retroviruses by DNA shuffling for improved stability and processing yields,”Nature Biotechnology, vol. 18, Dec. 2000, pp. 1279-1282.
Vigna et al., “Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy,”The Journal of Gene Medicine, vol. 2, 2000, pp. 308-316.
Wall et al., “Making Transgenic Livestock: Genetic Engineering on a Large Scale,”Journal of Cellular Biochemistry, vol. 49, 1992, pp. 113-120.
Wolfgang et al., “Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos,”PNAS, Vo. 98, No. 19, Sep. 11, 2001, pp. 10728-10732.
Yee et al., “A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficent infection of primary hepatocytes,”Proc. Natl. Acad. Sci. USA, vol. 91, Sep. 1994, pp. 9564-9568.
Yee et al., “Generation of High-Titer Pseudotyped Retroviral Vectors with Very Broad Host Range,”Methods in Cell Biology, vol. 43, Chapter 5, 1994, pp. 99-112.
Zufferey et al., “Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo,”Nature Biotechnology, vol. 15, Sep. 1997, pp. 871-875.
R.M. Shuman, “Production of transgenic birds”, Experientia, 1991, p. 902-905, vol. 47, Switzerland.
Joe Alper, “Hatching the Golden Egg: A New Way to Make Drugs”, Science Magazine, May 2, 2003, p. 729-730, vol. 300, Louisville, Colorado.
Bednarik et al., “Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency”, EMBO Journal, 1990, pp. 1157-1164, vol. 9, No. 4, Oxford University Press.
Bendarik et al., “Methylation as a Modulator of Expression of Human Immunodeficiency Virus”, Journal of Virology, Apr. 1987, pp. 1253-1257, vol. 61, No. 4, American Society for Microbiology.
Scott et al., “Generation of tissue-specific transgenic birds with lentiviral vectors”, PNAS, Nov. 8, 2005, pp. 16443-16447, vol. 102, No. 45.
Yang et al., “Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells”, PNAS, Mar. 22, 2005, pp. 4518-4523, vol. 102, No. 12.
Asano T et al., “Highly efficient gene transfer into primate embryonic stem cell with a simian lentivirus vector”, Molecular Therapy, Aug. 2002, pp. 162-167, vol. 6, No. 2, San Diego, CA, US.
Blomer U et al., “Highly Efficient and sustained gene transfer in adult neurons with a lentivirus vector”, Journal of Virology, Sep. 1997, vol. 71, No. 9, US.
Bosselman R A et al., “Germline transmission of exogenous genes in the chicken”, Science, Jan. 27, 1989, pp. 533-535, vol. 243, No. 4890.
Briskin M J et al., “Heritiable retroviral transgene are highly expressed in chickens”, Proceedings of the National Academy of Sciences of the United States of America, pp. 1736-1740, vol. 88, No. 5.
Cameron E R, “Recent Advances in Transgenic Technology,” Molecular Biotechnology, 1997, vol. 7.
Chapman Susan C et al., “Ubiquitous GFP expression in transgenic chickens using a lentiviral vector”, Mar. 2005, pp. 935-940, vol. 132, No. 5, Cambridge, MA.
Chan A W S et al., “Transgenic cattle produced by reverse-transcribed gene transfer in oocytes,” Proc. Natl. Acad. Sci USA, Nov. 1998, vol. 95, pp. 14028-14033.
Chan A W S et al. “Transgenic Monkeys Produced by Retroviral Gene Transfer Into Mature Oocytes” Science, Jan. 12, 2001, vol. 291.
Charreau Betrice et al., “Transgenesis in rats: Technical aspects and models”, Transgenic Research, pp. 223-234, vol. 5, No. 4.
Cowan P J et al., “Targeting gene expression to endothelium in transgenic animals: a comparison of the human ICAM-2, PECAM-1 and endoglin promoters,” Xenotransplantation, 2001, 10:223-231.
Duff, K et al., “Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1,” Nature, Oct. 24, 1996, vol. 383.
Gage F H, Cell Therapy, Nature, Apr. 30, 1998, vol. 392.
Gerlai R “Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?” Trends Neurosci. 1996, 19, 177-181.
Gropp M et al., “Stable genetic modification of human embryonic stem cells by lentiviral vectors”, Molecular Therapy, Feb. 2003, pp. 281-287, vol. 7, No. 2, San Diego, CA, US.
Hamaguchi I et al., “Lentivirus vector gene expression during es cell-derived hematopoietic development in vitro”, Journal
Baltimore David
Hong Elizabeth J.
Lois-Caballe Carlos
Pease Shirley
California Institute of Technology
Knobbe Martens Olson & Bear LLP
Schnizer Richard
LandOfFree
Method for producing transgenic birds and fish does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing transgenic birds and fish, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing transgenic birds and fish will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2759803